Details for New Drug Application (NDA): 208943
✉ Email this page to a colleague
NDA 208943 describes CORPHEDRA, which is a drug marketed by Endo Operations and is included in one NDA. It is available from two suppliers. Additional details are available on the CORPHEDRA profile page.
The generic ingredient in CORPHEDRA is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
The generic ingredient in CORPHEDRA is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
Summary for 208943
| Tradename: | CORPHEDRA |
| Applicant: | Endo Operations |
| Ingredient: | ephedrine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 208943
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Increased Norepinephrine Activity |
Medical Subject Heading (MeSH) Categories for 208943
Suppliers and Packaging for NDA: 208943
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943 | NDA | Endo USA, Inc. | 42023-216 | 42023-216-83 | 25 VIAL in 1 CARTON (42023-216-83) / 1 mL in 1 VIAL |
| CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943 | NDA | Endo USA, Inc. | 42023-216 | 42023-216-25 | 25 VIAL in 1 CARTON (42023-216-25) / 1 mL in 1 VIAL (42023-216-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/ML (50MG/ML) | ||||
| Approval Date: | Jan 27, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
